Webcasts

Nov 13, 2018
Sponsored Content
Premier Research's Andreas Schneiner and Barry Dussault will discuss the pathway of turning the potential of disease modification success in Parkinson’s disease into a reality.

Live: Tuesday, Nov. 13, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CEST / On Demand: available unitl Nov. 13, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act/therapies
Nov 13, 2018
Sponsored Content
This webcast will provide insights in to the better understanding of vaccine delivery to promote long-lived and effective responses with T-cell Responses measurements into clinical trials.

Live: Tuesday, November 13, 2018 at 10am EDT | 9am CDT | 8am PDT / On demand: available until Nov. 13, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act/biomarkers
Nov 08, 2018
Sponsored Content
This webcast will provide insights in to the better understanding of vaccine delivery to promote long-lived and effective responses with T-cell Responses measurements into clinical trials.

Live: Thursday, Nov. 8, 2018 at 3pm GMT | 4pm CET / On demand: available until Nov. 13, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act/biomarkers
Nov 06, 2018
Sponsored Content
Analgesic experts, Michael Kuss, Scott Millard, and Dr. Michael Skinner will discuss the intricacy of neuropathic pain clinical trials and the best avenues to take in overcoming the challenges surrounding them.

Live: Tuesday, Nov. 6, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CET / On demand: available after final airing until Nov. 6, 2019. Register free: http://www.appliedclinicaltrialsonline.com/act/PainStudies
Nov 01, 2018
Sponsored Content
By IQVIA
IQVIA’s NASH Center of Excellence is excited to share new and innovative strategies for some of NASH’s most challenging questions.

Live: Thursday, Nov. 1, 2018, 11am EST / On demand: available after airing until Nov. 1, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act/Strategies
Oct 11, 2018
Sponsored Content
Our knowledge of individual tumors and its microenvironment has evolved considerably in the last 10 years. In the webcast, we will discuss a myriad of factors, including immune cell activity, that can be derived from genomic measurement of tumor samples and the role they play in progression-free and overall survival from a pan-cancer viewpoint.

Live: Thursday, 11 October, 2018 at 11 am EDT | 8 am PDT | 1600 BST | 1700 CEST / On Demand available after airing until 11 October, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/immune
Oct 04, 2018
Sponsored Content
By IQVIA
Innovative approaches to Alzheimer’s drug development efforts are required. We must harness innovations in human and data sciences and technology to be more precise in how we identify and treat patients. We must bring treatments to Alzheimer’s patients faster than ever before. Learn from industry experts how advanced analytics is proactively driving faster recruitment and engagement of patients while optimizing drug development for Alzheimer’s – at the earliest stages of the disease, even before the patient is diagnosed.

Live: Thursday, October 4, 2018 at 11 am EDT / On Demand available after airing until October 4, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/change
Oct 03, 2018
Sponsored Content
Research reveals more than half of the clinical data professionals surveyed are not confident in the quality and completeness of their clinical data. Join this webcast to learn practical strategies to eliminate issues and restore confidence in data quality.

Live: Wednesday, 3 October, 2018 at 11 am EDT | 8 am PDT | 1600 BST | 1700 CEST / On Demand available after airing until 3 October, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/progression
Sep 27, 2018
Sponsored Content
By IQVIA
Artificial Intelligence (AI) is already having an impact on automating and improving Pharmacovigilance – develop your automation strategy and embrace change for the better!

Live: Thursday, September 27, 2018 at 11 am EDT / On Demand available after airing until September 27, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/transformative
Sep 25, 2018
Sponsored Content
Study startup time, widely considered a leading cause of lengthy cycle times, has stagnated for twenty years. Research from the Tufts Center for the Study of Drug Development indicated that clinical operations teams “satisfied” with their processes and those outperforming their competitors were adopters of technology.

Live: Tuesday, September 25, 2018 at 1 pm EDT | 12 pm CDT | 10 am PDT / On Demand available after airing until September 25, 2019.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/startup
native1_300x100
lorem ipsum